Treatment With Oxymorphone Is Patent-Eligible, Panel Says
WASHINGTON, D.C. — In a March 28 ruling, the Federal Circuit U.S. Court of Appeals found that a Delaware federal judge incorrectly deemed a method of administering controlled release oxymorphone to...To view the full article, register now.
Already a subscriber? Click here to view full article